These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32325870)

  • 1. Possible Role of Amyloidogenic Evolvability in Dementia with Lewy Bodies: Insights from Transgenic Mice Expressing P123H β-Synuclein.
    Fujita M; Ho G; Takamatsu Y; Wada R; Ikeda K; Hashimoto M
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct mechanisms of axonal globule formation in mice expressing human wild type α-synuclein or dementia with Lewy bodies-linked P123H β-synuclein.
    Sekigawa A; Fujita M; Sekiyama K; Takamatsu Y; Hatano T; Rockenstein E; La Spada AR; Masliah E; Hashimoto M
    Mol Brain; 2012 Sep; 5():34. PubMed ID: 23013868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A β-synuclein mutation linked to dementia produces neurodegeneration when expressed in mouse brain.
    Fujita M; Sugama S; Sekiyama K; Sekigawa A; Tsukui T; Nakai M; Waragai M; Takenouchi T; Takamatsu Y; Wei J; Rockenstein E; Laspada AR; Masliah E; Inoue S; Hashimoto M
    Nat Commun; 2010 Nov; 1():110. PubMed ID: 21045828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible alterations in β-Synuclein, the non-amyloidogenic homologue of α-Synuclein, during progression of sporadic α-synucleinopathies.
    Fujita M; Sekigawa A; Sekiyama K; Takamatsu Y; Hashimoto M
    Int J Mol Sci; 2012; 13(9):11584-11592. PubMed ID: 23109872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The loss of inhibitory C-terminal conformations in disease associated P123H β-synuclein.
    Janowska MK; Baum J
    Protein Sci; 2016 Jan; 25(1):286-94. PubMed ID: 26332674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibuprofen ameliorates protein aggregation and astrocytic gliosis, but not cognitive dysfunction, in a transgenic mouse expressing dementia with Lewy bodies-linked P123H β-synuclein.
    Sekiyama K; Fujita M; Sekigawa A; Takamatsu Y; Waragai M; Takenouchi T; Sugama S; Hashimoto M
    Neurosci Lett; 2012 Apr; 515(1):97-101. PubMed ID: 22459406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dementia with Lewy bodies-associated ß-synuclein mutations V70M and P123H cause mutation-specific neuropathological lesions.
    Psol M; Darvas SG; Leite K; Mahajani SU; Bähr M; Kügler S
    Hum Mol Genet; 2021 Apr; 30(3-4):247-264. PubMed ID: 33760043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early manifestation of depressive-like behavior in transgenic mice that express dementia with Lewy body-linked mutant β-synuclein.
    Fujita M; Hagino Y; Takamatsu Y; Shimizu Y; Takamatsu Y; Ikeda K; Hashimoto M
    Neuropsychopharmacol Rep; 2018 Jun; 38(2):95-97. PubMed ID: 30106256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?
    Fujita M; Sekigawa A; Sekiyama K; Sugama S; Hashimoto M
    J Neurol; 2009 Aug; 256 Suppl 3():286-92. PubMed ID: 19711118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of α- and β-Synucleins in the Axonal Pathology of Parkinson's Disease and Related Synucleinopathies.
    Sekigawa A; Takamatsu Y; Sekiyama K; Hashimoto M
    Biomolecules; 2015 May; 5(2):1000-11. PubMed ID: 25996784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Synuclein: An Enigmatic Protein with Diverse Functionality.
    Hayashi J; Carver JA
    Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immature-like molecular expression patterns in the hippocampus of a mouse model of dementia with Lewy body-linked mutant β-synuclein.
    Hagihara H; Fujita M; Umemori J; Hashimoto M; Miyakawa T
    Mol Brain; 2018 Jul; 11(1):38. PubMed ID: 29976232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-synuclein gene alterations in dementia with Lewy bodies.
    Ohtake H; Limprasert P; Fan Y; Onodera O; Kakita A; Takahashi H; Bonner LT; Tsuang DW; Murray IV; Lee VM; Trojanowski JQ; Ishikawa A; Idezuka J; Murata M; Toda T; Bird TD; Leverenz JB; Tsuji S; La Spada AR
    Neurology; 2004 Sep; 63(5):805-11. PubMed ID: 15365127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced lysosomal pathology caused by beta-synuclein mutants linked to dementia with Lewy bodies.
    Wei J; Fujita M; Nakai M; Waragai M; Watabe K; Akatsu H; Rockenstein E; Masliah E; Hashimoto M
    J Biol Chem; 2007 Sep; 282(39):28904-28914. PubMed ID: 17652097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excess membrane binding of monomeric alpha-, beta- and gamma-synuclein is invariably associated with inclusion formation and toxicity.
    Kim TE; Newman AJ; Imberdis T; Brontesi L; Tripathi A; Ramalingam N; Fanning S; Selkoe D; Dettmer U
    Hum Mol Genet; 2021 Nov; 30(23):2332-2346. PubMed ID: 34254125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein.
    Galvin JE; Uryu K; Lee VM; Trojanowski JQ
    Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13450-5. PubMed ID: 10557341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Disease-Associated P123H and V70M Mutations on β-Synuclein Fibrillation.
    Sharma K; Mehra S; Sawner AS; Markam PS; Panigrahi R; Navalkar A; Chatterjee D; Kumar R; Kadu P; Patel K; Ray S; Kumar A; Maji SK
    ACS Chem Neurosci; 2020 Sep; 11(18):2836-2848. PubMed ID: 32833434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model.
    Hashimoto M; Rockenstein E; Mante M; Crews L; Bar-On P; Gage FH; Marr R; Masliah E
    Gene Ther; 2004 Dec; 11(23):1713-23. PubMed ID: 15483670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of beta-synuclein in cortical neurons is associated with autophagy attenuation in the brains of dementia with Lewy body patients.
    Evans T; Kok WL; Cowan K; Hefford M; Anichtchik O
    Brain Res; 2018 Feb; 1681():1-13. PubMed ID: 29278715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
    Jellinger KA
    J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.